Badley AD - Search Results

1

Altering cell death pathways as an approach to cure HIV infection.

Badley AD, Sainski A, Wightman F, Lewin SR. Badley AD, et al. Cell Death Dis. 2013 Jul 11;4(7):e718. doi: 10.1038/cddis.2013.248. Cell Death Dis. 2013. PMID: 23846220 Free PMC article. Review.

2

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV. Badley AD, et al. J Clin Invest. 1998 Jul 1;102(1):79-87. doi: 10.1172/JCI2691. J Clin Invest. 1998. PMID: 9649560 Free PMC article.

3

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.

Badley AD, Parato K, Cameron DW, Kravcik S, Phenix BN, Ashby D, Kumar A, Lynch DH, Tschopp J, Angel JB. Badley AD, et al. Cell Death Differ. 1999 May;6(5):420-32. doi: 10.1038/sj.cdd.4400509. Cell Death Differ. 1999. PMID: 10381636

4

Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number.

Dockrell DH, Badley AD, Algeciras-Schimnich A, Simpson M, Schut R, Lynch DH, Paya CV. Dockrell DH, et al. Among authors: badley ad. AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1509-18. doi: 10.1089/088922299309793. AIDS Res Hum Retroviruses. 1999. PMID: 10580401

5

Mitochondrion-mediated apoptosis in HIV-1 infection.

Badley AD, Roumier T, Lum JJ, Kroemer G. Badley AD, et al. Trends Pharmacol Sci. 2003 Jun;24(6):298-305. doi: 10.1016/S0165-6147(03)00125-1. Trends Pharmacol Sci. 2003. PMID: 12823956 Review.

6

In vitro and in vivo effects of HIV protease inhibitors on apoptosis.

Badley AD. Badley AD. Cell Death Differ. 2005 Aug;12 Suppl 1:924-31. doi: 10.1038/sj.cdd.4401580. Cell Death Differ. 2005. PMID: 15761470 Review.

7

Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions.

Lum JJ, Schnepple DJ, Badley AD. Lum JJ, et al. Among authors: badley ad. AIDS. 2005 Jul 22;19(11):1125-33. doi: 10.1097/01.aids.0000176212.16205.23. AIDS. 2005. PMID: 15990565

8

Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.

Vlahakis SR, Bren GD, Algeciras-Schimnich A, Trushin SA, Schnepple DJ, Badley AD. Vlahakis SR, et al. Among authors: badley ad. Clin Pharmacol Ther. 2007 Sep;82(3):294-9. doi: 10.1038/sj.clpt.6100140. Epub 2007 Mar 14. Clin Pharmacol Ther. 2007. PMID: 17361127

9

Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4.

Trushin SA, Algeciras-Schimnich A, Vlahakis SR, Bren GD, Warren S, Schnepple DJ, Badley AD. Trushin SA, et al. Among authors: badley ad. J Immunol. 2007 Apr 15;178(8):4846-53. doi: 10.4049/jimmunol.178.8.4846. J Immunol. 2007. PMID: 17404265

10

Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.

Nie Z, Bren GD, Vlahakis SR, Schimnich AA, Brenchley JM, Trushin SA, Warren S, Schnepple DJ, Kovacs CM, Loutfy MR, Douek DC, Badley AD. Nie Z, et al. Among authors: badley ad. J Virol. 2007 Jul;81(13):6947-56. doi: 10.1128/JVI.02798-06. Epub 2007 Apr 18. J Virol. 2007. PMID: 17442709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters